低分子肝素钙与复方丹参治疗慢性肺源性心脏病急性加重期的临床观察

目的 观察低分子肝素钙与复方丹参对慢性肺源性心脏病急性加重期患者的治疗效果。方法 选择60例慢性肺源性心脏病急性加重期患者，随机分为治疗组和对照组，治疗组在常规治疗的基础上加用低分子肝素钙与复方丹参治疗，对照组采用常规治疗，两组均进行治疗前后血气分析和血液流变学检验。结果 治疗组显效率为53．3％。总有效率为83．3％，对照组显效率为30％，总有效率为56．7％。两组在临床疗效上有统计学显著性差异；治疗组不良反应轻微。发生率为6．7％。结论 治疗组方法能有效地降低血液黏滞度．明显改善慢性肺源性心脏病急性加重期患者的临床症状。

Clinical observation on the efficiency of low molecular heparinate calcium combined with salvia miltiorrhizae compound in the treatment of chronic pulmonary heart disease at acute exacerbation stage

Objective To observe the clinical efficiency of low molecular heparinate calcium combined with salvia miltiorrhizae co. in the treatment of chronic pulmonary heart disease at acute exacerbation stage. Methods Sixty patients with chronic pulmonary heart disease at acute exacerbation stage were randomly divided into two groups: treatment group(therapeutic group, n = 30) and control group(conventional therapy, n = 30), blood gas analysis and hemorheology were compared between the two groups. Results Excellent efficiency was 53.3% in treatment group, while it was 30% in control, the total effective rate was 83.3% in treatment group, while it was 56.7% in control, and adverse effect in treatment group was small with the incidence rate of 6.7%. Conclusion In treatment group, blood viscosity was efficiently decreased and clinical signs and symptoms were obviously improved in patients with chronic pulmonary heart disease at acute exacerbation stage.